Parametric Portfolio Associates’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$887K Sell
27,557
-4,887
-15% -$168K ﹤0.01% 2833
2021
Q4
$1.45M Sell
32,444
-554
-2% -$26.2K ﹤0.01% 2626
2021
Q3
$1.67M Sell
32,998
-31,211
-49% -$1.76M ﹤0.01% 2534
2021
Q2
$5.04M Buy
64,209
+20,390
+47% +$1.26M ﹤0.01% 1849
2021
Q1
$2.5M Sell
43,819
-2,596
-6% -$174K ﹤0.01% 2630
2020
Q4
$3.89M Sell
46,415
-10,002
-18% -$605K ﹤0.01% 2236
2020
Q3
$2.02M Buy
56,417
+40,027
+244% +$1.21M ﹤0.01% 2504
2020
Q2
$396K Buy
16,390
+4,514
+38% +$106K ﹤0.01% 3367
2020
Q1
$208K Sell
11,876
-46
-0.4% -$960 ﹤0.01% 3535
2019
Q4
$208K Sell
11,922
-344
-3% -$5.73K ﹤0.01% 3730
2019
Q3
$188K Buy
+12,266
New +$234K ﹤0.01% 3728

Other funds holding DNLI